Dr. Peter Jones elected to National Academy of Sciences to advise nation on medical and epigenomic policy and direction

Learn More

Stanley Fahn, M.D., honored by Van Andel Institute

Founder of movement disorders field to receive Parkinson’s award 

Learn More

Promising respiratory drug
focus of new clinical trial for
Parkinson’s disease

Learn More
Linked Clinical Trials scientific committee
Through biomedical research and science education Van Andel Institute is committed to improving the health and enhancing the lives of current and future generations.

Learn More

Hot Papers

Read All

Epigenetic determinants of cancer
Stephen B. Baylin and Peter A. Jones
2016 | Cold Spring Harbor Perspectives in Biology

Ubiquitination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1.
Nucifora, Frederick C., Jr., Leslie G. Nucifora, Chee-Hoe Ng, Nicolas Arbez, Yajuan Guo, Elaine Roby, Vered Shani, Simone Engelender, Dong Wei, Xiao-Fang Wang, Tianxia Li, Darren J. Moore, Olga Pletnikova, Juan C. Troncoso, Akira Sawa, Ted M. Dawson, Wanli Smith, Kah-Leong Lim, and Christopher A. Ross.
2016 |  Nature Communications

Receptor tyrosine kinase Met promotes cell survival via kinase-independent maintenance of integrin α3β1
Tesfay, Lia, Veronique V. Schulz, Sander B. Frank, Laura E. Lamb, and Cindy K. Miranti
In press | Molecular Biology of the Cell


See All Events

Epigenomics at VARI

July 25-29, 2016

Danny R. Welch, Ph.D.

August 10, 2016

Matt LaVoie, Ph.D.

August 17, 2016